Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

N-ras mutation in acute myeloid leukemia: incidence, prognostic significance and value as a marker of minimal residual disease.

Pathology - 1 Jan 1993

Casey G, Rudzki Z, Roberts M, Hutchins C, Juttner C

Abstract excerpt

The polymerase chain reaction (PCR) and allele specific oligonucleotide (ASO) hybridization have been used to investigate the incidence of N-ras mutation in acute myeloid leukemia (AML). The prognostic significance of these mutations and their value as markers of minimal residual disease have also been assessed. Mutated N-ras alleles were detected in 9 of 69 AML patients (13%). No significant difference in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Genes, ras

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Incidence

Share to Leukemia, Myeloid, Acute

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 8316501
DOI: 10.3109/00313029309068903

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

N-ras mutation in acute myeloid leukemia: incidence, prognostic significance and value as a marker of minimal residual disease.PMID 8316501Read ↗

Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.Semantic proximity Read ↗

N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.Semantic proximity Read ↗

N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome.Semantic proximity Read ↗

Allele-specific enrichment: a method for the detection of low level N-ras gene mutations in acute myeloid leukemia.Semantic proximity Read ↗

Analysis of N-ras gene mutations in acute myeloid leukemia by allele specific restriction analysis.Semantic proximity Read ↗

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.Semantic proximity Read ↗

A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia.Semantic proximity Read ↗

Detection of minimal acute myeloid leukemia cells in bone marrow by probing for mutated ras oncogenes using the polymerase chain reaction.Semantic proximity Read ↗

The incidence and prognostic significance of mutations in codon 13 of the N-ras gene in acute myeloid leukemia.Semantic proximity Read ↗

N-ras gene mutations in acute myeloid leukemia: accurate detection by solid-phase minisequencing.Semantic proximity Read ↗

Persistence of an activating N-RAS oncogene mutation in clonogenic progenitor cells from an acute myeloid leukaemia patient in remission.Semantic proximity Read ↗

Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.